Renew Biopharma employs synthetic biology to create engineered enzymes that produce novel molecules that cross the blood brain barrier, and target specific receptors associated with neuroinflammation and chronic pain.
Who We Are
Renew employs rational enzyme engineering to modify and improve enzymes to create and manufacture novel molecules. This allows us to design these molecules for potency and efficacy for specific, targeted indications.
Key Strengths
RENEW’S UNMATCHED ABILITIES ARE ATTRIBUTED TO THREE KEY FACTORS:
Leveraging a portfolio of intellectual property including licensed issued patents and robust new pending patents
Our Mission
To harness microbial synthetic biology for the purpose of improving human health.
Our Goal
To produce proprietary alkylresorcinol-scaffold derivatives that lead to powerful new therapeutics for neuroinflammatory diseases.
Contact Us
General Inquiries: info@renewbiopharma.com
Press Inquiries: press@renewbiopharma.com